MedPacto Inc
MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
MedPacto Inc (235980) - Total Liabilities
Latest total liabilities as of September 2025: ₩3.19 Billion KRW
Based on the latest financial reports, MedPacto Inc (235980) has total liabilities worth ₩3.19 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MedPacto Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how MedPacto Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MedPacto Inc Competitors by Total Liabilities
The table below lists competitors of MedPacto Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Envela Corp
NYSE MKT:ELA
|
USA | $29.87 Million |
|
Pelican Acquisition Corporation Ordinary Shares
NASDAQ:PELI
|
USA | $311.25K |
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
India | ₹229.98 Million |
|
DMS Co.Ltd
KQ:068790
|
Korea | ₩135.93 Billion |
|
Prospect Resources Ltd
AU:PSC
|
Australia | AU$2.30 Million |
|
Cemindo Gemilang Tbk PT
JK:CMNT
|
Indonesia | Rp13.97 Trillion |
|
Summit Midstream Corporation
NYSE:SMC
|
USA | $1.32 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down MedPacto Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 27.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MedPacto Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MedPacto Inc (2017–2024)
The table below shows the annual total liabilities of MedPacto Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩3.04 Billion | -68.20% |
| 2023-12-31 | ₩9.57 Billion | -87.31% |
| 2022-12-31 | ₩75.36 Billion | -16.08% |
| 2021-12-31 | ₩89.80 Billion | +3161.75% |
| 2020-12-31 | ₩2.75 Billion | +37.33% |
| 2019-12-31 | ₩2.00 Billion | -92.64% |
| 2018-12-31 | ₩27.24 Billion | +134.27% |
| 2017-12-31 | ₩11.63 Billion | -- |